Drug Shortage Report for AMPICILLIN SODIUM FOR INJECTION BP
| Report ID | 68116 |
| Drug Identification Number | 02462346 |
| Brand name | AMPICILLIN SODIUM FOR INJECTION BP |
| Common or Proper name | Ampicillin |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | AMPICILLIN |
| Strength(s) | 2G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 20 mL/Vial x 10 |
| ATC code | J01CA |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2018-11-29 |
| Estimated end date | |
| Actual end date | 2018-12-12 |
| Shortage status | Resolved |
| Updated date | 2018-12-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2018-12-13 | French | Compare |
| v4 | 2018-12-13 | English | Compare |
| v3 | 2018-11-30 | English | Compare |
| v2 | 2018-11-29 | French | Compare |
| v1 | 2018-11-29 | English | Compare |
Showing 1 to 5 of 5